Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine-Reference-Cited by-同舟云学术

Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine

Published:2017-08 Issue:7 Volume:28 Page:801-807
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Lampropoulos Stylianos,Roditis Pavlos,Koulouris Efstathios,Zafiris Aristides,Tzimou Mirto,Kyratlidis Konstantinos,Pavlidis Konstantinos,Godwin Solace A.,Kosmas Christos

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference14 articles.

1. The Prodrugs of 5-Fluorouracil

2. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer

3. Coronary artery spasm induced by 5-fluorouracil

4. Fluorouracil Cardiotoxicity

5. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A smart capecitabine imprinted nanocontainer with the dual-responsive performance to pH/NIR light;Materials Today Communications;2024-08

2. Design of pH-responsive molecularly imprinted polymer as a carrier for controlled and sustainable capecitabine release;Analytica Chimica Acta;2024-08

3. Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicity;Pharmacogenomics;2021-07

4. Molecular absorption and mass spectrometry for complementary analytical study of fluorinated drugs in animal organisms;Journal of Analytical Atomic Spectrometry;2020

5. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment;Current Pharmaceutical Design;2019-02-27